FDA Grants Orphan Drug Status to Sanofi’s Rilzabrutinib: A New Hope for wAIHA, IgG4-RD, and Beyond
Rilzabrutinib, an investigational oral BTK inhibitor, has received orphan drug designation from the FDA for treating warm autoimmune hemolytic an ...
Solease and Eneco have formed a joint venture to exclusively promote Eneco’s new business product, Eneco GroenGebouw™, a full-service concept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback